CareTrust CTRE SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Other Addition
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Other Addition at other companies
Other financials
Where this comes from
Reported directly by CareTrust in its filing.
Tagged under the XBRL concept us-gaap:MortgageLoansOnRealEstateOtherAdditions.
The official record: CareTrust’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about CareTrust's sec schedule, 12-29, real estate companies, investment in mortgage loans on real estate, other addition.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CareTrust's SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, other addition?
- CareTrust (CTRE) reported SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, other addition of $161.75K in Q4 2025.
- How has CareTrust's SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, other addition changed year-over-year?
- CareTrust's SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, other addition decreased by 75.1% year-over-year, from $650K to $161.75K.
- What is the long-term trend for CareTrust's SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, other addition?
- Over 3 years (2021 to 2025), CareTrust's SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, other addition has grown at a 61.0% compound annual growth rate (CAGR), from $155K to $647K.
- What does SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, other addition mean?
- Miscellaneous additions to the mortgage loan portfolio, such as capitalized interest, loan modifications, or adjustments to the carrying value of debt investments. This reflects changes in the value of the loan book beyond new originations.